Minerva anestesiologica
-
Minerva anestesiologica · Nov 1996
Practice Guideline Guideline[Recommendations for anesthesiologic treatment in non-cardiac surgery in congenital cardiopathy in neonatal and pediatric age. Italian Society of Anesthesia, Resuscitation and Intensive Therapy Group. Anesthesia and Resuscitation in Cardiothoracic Surgery].
-
Minerva anestesiologica · Nov 1996
Clinical Trial Controlled Clinical Trial[Light-guided intubation using Trachlight].
A new intubating transilluminated device (Trachlight) has been recently proposed as an alternative to tracheal intubation with direct laryngoscopy. ⋯ Orotracheal intubation using Trachlight appears to be an effective and easy to learn technique, being also easy, safe and fast to carry out. The comparison with direct laryngoscopy showed the same speed and effectiveness even on patients with difficult intubation.
-
Minerva anestesiologica · Nov 1996
Review[Balanced spinal analgesia in the treatment of oncologic pain. Review of the literature].
Certain types of cancer pain fail to respond well either to systemic drug therapy or to spinal opioids because of the occurrence of intolerable adverse effects. In addition to spinal opioids other drugs may produce an antinociceptive effect when administered by the spinal route, such as local anesthetics, NSAID, alpha 2-agonists, calcium-channel blockers, NMDA antagonists, cholinergic drugs, peptides such as somatostatin, octreotide or calcitonin, adenosine agonists, benzodiazepines, neurokinin and cholecystokinin antagonists, nitric oxide synthase inhibitors, corticosteroids, and enkephalinase inhibitors. All these drugs may be administered in combination between them, realising the so called balanced spinal analgesia. ⋯ Analysis of the presented data shows that the spinal synergism between opioids-local anesthetics and opioids-alpha 2-agonists can be useful in the treatment of opioid refractory cancer pain. Furthermore, the use of cholinergic drugs combined with opioids and alpha 2-agonists may be promising. Finally, even if the synergism between NSAID or NMDA antagonists with opioids or alpha 2-agonists have been proved, at the moment their use in man by the spinal route is not advisable because of the absence of adequate studies on their neurotoxicity and adverse effects.